Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Recombinant protein expression and monoclonal antibody preparation of HCCR

Expression,purification and preparation of monoclonal antibody of HCA518 protein

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Identification of hepatocellular carcinoma antigens by serological analysis of recombinant cDNA expression library and detection of hcct-19 expression in human tissues and cell lines

Preparation of the Anti-Human Chorionic Gonadotrophin Β-Subunit Monoclonal Antibodies Based on the Genetic Immunization with Recombinant Plasmid and Characterization of Its Biological Properties

A Novel Polyclonal Antibody Against Human Cytomegalovirus: General Characteristics and Potential Application in Diagnosis

[Cloning and Sequencing of VL and VH Genes from a Novel Clone ZCH-7-2F9 of Anti-Hcd14 Monoclonal Antibody].

Preparation and Application of Monoclonal Antibodies Against Hepatitis C Virus Nonstructural Proteins.

Expression and Significance of Human Cervical Cancer Oncogene (HCCR) Mrna in Hepatocellular Carcinoma Tissues

Cloning and Expression of Fragment with 2148 Bp from Caga Gene from Isolates of a Helicobacter Pylori and Identification of Immunogenicity of the Recombinant Proteins

Cloning of the Cdna Fragment of a Tumor Associated Antigen Recognized by Monoclonal Antibody 3H11

Preparation and characterization of monoclonal antibody against hTSC29 pep-tides

Preparation of new gene cell cycle related tumour high-expression gene monoclonal antibody and its application

Prokaryotic Expression of Soluble NH2-terminal Fragment of Glypican-3 and Preparation of Anti-Gpc3 Antibody

Polyclonal Antibody Production Against Rgpc3 and Their Application in Diagnosis of Hepatocellular Carcinoma

Prokaryotic Expression and Purification of Minor Capsid Protein L2 Derived from Human Papillomavirus 58 and Preparation of Monoclonal Antibody

Preparation of anti-human esophageal cancer invasion and metastasis functional monoclonal antibody

[Expression of GST-HAI-1 Fusion Protein and Development of Monoclonal Antibody Against Human Hepatocyte Growth Factor Activator Inhibitor 1].

Reconstruction and Expression of Chimeric Anti-Hbx Antibody in Escherichia Coli

Molecular Cloning of a Tumor-Associated Antigen Recognized by Monoclonal Antibody 3H11

Preparation and Characterization of the Monoclonal Antibody Against HSPC238 Antigen